Literature DB >> 21188174

Identification of urinary biomarkers of colon inflammation in IL10-/- mice using Short-Column LCMS metabolomics.

Don Otter1, Mingshu Cao, Hui-Ming Lin, Karl Fraser, Shelley Edmunds, Geoff Lane, Daryl Rowan.   

Abstract

The interleukin-10-deficient (IL10(-/-)) mouse develops colon inflammation in response to normal intestinal microflora and has been used as a model of Crohn's disease. Short-Column LCMS metabolite profiling of urine from IL10(-/-) and wild-type (WT) mice was used, in two independent experiments, to identify mass spectral ions differing in intensity between these two genotypes. Three differential metabolites were identified as xanthurenic acid and as the glucuronides of xanthurenic acid and of α-CEHC (2,5,7,8-tetramethyl-2-(2'-carboxyethyl)-6-hydroxychroman). The significance of several differential metabolites as potential biomarkers of colon inflammation was evaluated in an experiment which compared metabolite concentrations in IL10(-/-) and WT mice housed, either under conventional conditions and dosed with intestinal microflora, or maintained under specific pathogen-free (SPF) conditions. Concentrations of xanthurenic acid, α-CEHC glucuronide, and an unidentified metabolite m/z 495(-)/497(+) were associated with the degree of inflammation in IL10(-/-) mice and may prove useful as biomarkers of colon inflammation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21188174      PMCID: PMC3005964          DOI: 10.1155/2011/974701

Source DB:  PubMed          Journal:  J Biomed Biotechnol        ISSN: 1110-7243


  40 in total

1.  Synthesis and analysis of conjugates of the major vitamin E metabolite, alpha-CEHC.

Authors:  Simon A S Pope; Guillaume E Burtin; Peter T Clayton; David J Madge; David P R Muller
Journal:  Free Radic Biol Med       Date:  2002-09-15       Impact factor: 7.376

2.  High-throughput direct-infusion ion trap mass spectrometry: a new method for metabolomics.

Authors:  Albert Koulman; Brian A Tapper; Karl Fraser; Mingshu Cao; Geoffrey A Lane; Susanne Rasmussen
Journal:  Rapid Commun Mass Spectrom       Date:  2007       Impact factor: 2.419

3.  Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-kappaB target gene expression.

Authors:  Yatrik M Shah; Xiaochao Ma; Keiichirou Morimura; Insook Kim; Frank J Gonzalez
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-12-14       Impact factor: 4.052

4.  Metabolomics reveals a novel vitamin E metabolite and attenuated vitamin E metabolism upon PXR activation.

Authors:  Joo-Youn Cho; Dong Wook Kang; Xiaochao Ma; Sung-Hoon Ahn; Kristopher W Krausz; Hans Luecke; Jeffrey R Idle; Frank J Gonzalez
Journal:  J Lipid Res       Date:  2009-01-13       Impact factor: 5.922

Review 5.  Tryptophan and the immune response.

Authors:  John R Moffett; Ma Aryan Namboodiri
Journal:  Immunol Cell Biol       Date:  2003-08       Impact factor: 5.126

6.  Advanced data-mining strategies for the analysis of direct-infusion ion trap mass spectrometry data from the association of perennial ryegrass with its endophytic fungus, Neotyphodium lolii.

Authors:  Mingshu Cao; Albert Koulman; Linda J Johnson; Geoffrey A Lane; Susanne Rasmussen
Journal:  Plant Physiol       Date:  2008-02-20       Impact factor: 8.340

Review 7.  IDO expression by dendritic cells: tolerance and tryptophan catabolism.

Authors:  Andrew L Mellor; David H Munn
Journal:  Nat Rev Immunol       Date:  2004-10       Impact factor: 53.106

8.  Is vitamin E depleted in Crohn's disease at initial diagnosis?

Authors:  F Kuroki; M Iida; M Tominaga; T Matsumoto; K Kanamoto; M Fujishima
Journal:  Dig Dis       Date:  1994 Jul-Aug       Impact factor: 2.404

9.  TGF-beta and kynurenines as the key to infectious tolerance.

Authors:  Maria L Belladonna; Ciriana Orabona; Ursula Grohmann; Paolo Puccetti
Journal:  Trends Mol Med       Date:  2009-01-21       Impact factor: 11.951

10.  HMDB: the Human Metabolome Database.

Authors:  David S Wishart; Dan Tzur; Craig Knox; Roman Eisner; An Chi Guo; Nelson Young; Dean Cheng; Kevin Jewell; David Arndt; Summit Sawhney; Chris Fung; Lisa Nikolai; Mike Lewis; Marie-Aude Coutouly; Ian Forsythe; Peter Tang; Savita Shrivastava; Kevin Jeroncic; Paul Stothard; Godwin Amegbey; David Block; David D Hau; James Wagner; Jessica Miniaci; Melisa Clements; Mulu Gebremedhin; Natalie Guo; Ying Zhang; Gavin E Duggan; Glen D Macinnis; Alim M Weljie; Reza Dowlatabadi; Fiona Bamforth; Derrick Clive; Russ Greiner; Liang Li; Tom Marrie; Brian D Sykes; Hans J Vogel; Lori Querengesser
Journal:  Nucleic Acids Res       Date:  2007-01       Impact factor: 16.971

View more
  11 in total

Review 1.  Clinical metabolomics paves the way towards future healthcare strategies.

Authors:  Sebastiano Collino; François-Pierre J Martin; Serge Rezzi
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

Review 2.  Biomarkers in inflammatory bowel disease: current practices and recent advances.

Authors:  Heba N Iskandar; Matthew A Ciorba
Journal:  Transl Res       Date:  2012-02-01       Impact factor: 7.012

3.  PPARβ/δ modulates ethanol-induced hepatic effects by decreasing pyridoxal kinase activity.

Authors:  Maryam Goudarzi; Takayuki Koga; Combiz Khozoie; Tytus D Mak; Boo-Hyon Kang; Albert J Fornace; Jeffrey M Peters
Journal:  Toxicology       Date:  2013-07-10       Impact factor: 4.221

Review 4.  Urinary metabolites as noninvasive biomarkers of gastrointestinal diseases: A clinical review.

Authors:  Irene Sarosiek; Rudolf Schicho; Pedro Blandon; Mohammad Bashashati
Journal:  World J Gastrointest Oncol       Date:  2016-05-15

Review 5.  Indoleamine 2,3 dioxygenase in intestinal disease.

Authors:  Matthew A Ciorba
Journal:  Curr Opin Gastroenterol       Date:  2013-03       Impact factor: 3.287

6.  Changes in bowel microbiota induced by feeding weanlings resistant starch stimulate transcriptomic and physiological responses.

Authors:  Wayne Young; Nicole C Roy; Julian Lee; Blair Lawley; Don Otter; Gemma Henderson; Mark J McCann; Gerald W Tannock
Journal:  Appl Environ Microbiol       Date:  2012-07-13       Impact factor: 4.792

7.  Metabolomic applications to decipher gut microbial metabolic influence in health and disease.

Authors:  François-Pierre J Martin; Sebastiano Collino; Serge Rezzi; Sunil Kochhar
Journal:  Front Physiol       Date:  2012-04-26       Impact factor: 4.566

Review 8.  Metabolomics: is it useful for inflammatory bowel diseases?

Authors:  Martin Storr; Hans J Vogel; Rudolf Schicho
Journal:  Curr Opin Gastroenterol       Date:  2013-07       Impact factor: 3.287

9.  Metabolomic profiles are gender, disease and time specific in the interleukin-10 gene-deficient mouse model of inflammatory bowel disease.

Authors:  Victor K Tso; Beate C Sydora; Rae R Foshaug; Thomas A Churchill; Jason Doyle; Carolyn M Slupsky; Richard N Fedorak
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

10.  Translational Potential of Metabolomics on Animal Models of Inflammatory Bowel Disease-A Systematic Critical Review.

Authors:  Lina Almind Knudsen; Rasmus Desdorf; Sören Möller; Signe Bek Sørensen; Axel Kornerup Hansen; Vibeke Andersen
Journal:  Int J Mol Sci       Date:  2020-05-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.